WO2020060159A1 - Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci - Google Patents

Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci Download PDF

Info

Publication number
WO2020060159A1
WO2020060159A1 PCT/KR2019/012002 KR2019012002W WO2020060159A1 WO 2020060159 A1 WO2020060159 A1 WO 2020060159A1 KR 2019012002 W KR2019012002 W KR 2019012002W WO 2020060159 A1 WO2020060159 A1 WO 2020060159A1
Authority
WO
WIPO (PCT)
Prior art keywords
rope
metal
therapy
biodegradable
metal wire
Prior art date
Application number
PCT/KR2019/012002
Other languages
English (en)
Korean (ko)
Inventor
조성윤
Original Assignee
랩앤피플주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 랩앤피플주식회사 filed Critical 랩앤피플주식회사
Priority to EP19862122.9A priority Critical patent/EP3854316B1/fr
Priority to CN201980057740.XA priority patent/CN112672698A/zh
Priority to US17/276,783 priority patent/US20210353822A1/en
Priority to JP2021513324A priority patent/JP7320301B2/ja
Priority claimed from KR1020190114080A external-priority patent/KR102310568B1/ko
Publication of WO2020060159A1 publication Critical patent/WO2020060159A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/14—Post-treatment to improve physical properties

Definitions

  • the present invention relates to a rope for meditation therapy and a needle device including the same, and more particularly, to a rope for meditation therapy using a biodegradable metal and a needle device including the same.
  • THREAD EMBEDDING THERAPY is one of the blood-placement therapies, and it is a therapy that treats diseases by continuously stimulating the bloodstream by embedding foreign substances in the blood. Its purpose is to increase the therapeutic effect by extending the stimulation time for blood pressure as well as the physicochemical stimulation of the deposit.
  • Animal tissues such as the dog's spleen, drugs, gangwon, and suicides were used, and metal tools and catguts are currently used.
  • chromic surgical threads are mainly used, and sutures based on polydioxanone (PDO), which has proven to be safe and has little tissue reaction and melts after a certain period of time, are widely used.
  • PDO polydioxanone
  • the treatment using the chamber was recorded in the ⁇ Taipei Hyeminbang '', compiled in around 982 by the Taepyeong Hyeminhwa Bureau of Songdae, and it was recorded that the treatment was performed on the blood level with a drug in the thread called psoriasis therapy or implantation therapy.
  • acupuncture medicine textbooks used in oriental medicine education acupuncture is divided into acupuncture according to the stimulation site, acupuncture according to the stimulation method, and acupuncture according to a specific theory. It corresponds to the law ( ⁇ ⁇ ⁇ ⁇ ⁇ ).
  • psoriasis therapy As an indication of psoriasis therapy, it is a level that treats a variety of diseases such as acute illness beyond the border between chronic and ischemic conditions, and there are more than 200 types of diseases that can be treated. Its contents are internal medicine, surgery, gynecology, pediatrics, and dermatology. , Otolaryngology, musculoskeletal disorders and other fields.
  • psoriasis therapy is widely used as a method for inserting a lifting wire such as a lifting wire to improve skin aging or wrinkles.
  • a lifting wire such as a lifting wire to improve skin aging or wrinkles.
  • the specific causes of skin aging, such as wrinkles and loss of elasticity, have not been clearly identified in long-term studies, but by inserting an implant under the skin, such as by inserting a lifting wire subcutaneously, a prominent direct effect similar to that of a surgical method can be obtained.
  • Lifting wire not only has the mechanical effect of pulling the skin under the skin, but also promotes collagen production in the dermal layer as the cell tissue around the inserted lifting wire is healed and regenerated, thereby revitalizing the skin elasticity and wrinkles. have.
  • polydioxanone As the material of the suture, polydioxanone (PDO) is the most commonly used, and recently, the use of poly-L-lactic acid (PLLA) material in terms of characteristics that do not decompose longer in the body and human-friendly properties Is increasing.
  • polylactic acid (PLA), polyglycolic acid (PGA), polycarpolactone (PCL), glycolide-lactide copolymer (PGLA) and copolymers thereof are considered in addition to decomposition speed, mechanical strength and ductility.
  • (Copolymer) etc. are biodegradable materials that can be used as sutures for psoriasis therapy.
  • biodegradable polymer materials are basically weak in strength, there is a great risk of unwanted breakage during the procedure, and the biocompatibility is relatively low compared to some approved metal materials, causing pain and inflammation. Occasionally, a biorejection reaction of the back occurs.
  • Korean Patent Registration No. 10-1641299 discloses a metal coating thin film by depositing metal ions or metal particles on the surface of a biodegradable visible plume so that body fluid and visible plume are formed.
  • a metal coating thin film by depositing metal ions or metal particles on the surface of a biodegradable visible plume so that body fluid and visible plume are formed.
  • gold, silver, and titanium which are known to have high biocompatibility as a deposited metal component, are limited, and thus, a clear solution to decomposition of the metal component in the body is not proposed.
  • the structure is deposited on the polymer suture in the form of a thin film, a solution to the strength reduction of the polymer material, which is a major problem in the related art, has not been suggested.
  • the visible plume does not substantially perform the function of the chamber.
  • the present inventors have studied the biocompatibility and maintenance of strength of biodegradable Mg-Ca-Zn-based alloy bone graft material (Cho SY, Chae SW, Choi KW, Seok HK, Kim YC, Jung JY, Yang SJ) , Kwon GJ, Kim JT, Assad M. 2012.Biocompatibility and strength retention of biodegradable Mg-Ca-Zn alloy bone implants.J Biomed Mater Res Part B 2012: 00B: 000-000).
  • the biocompatibility and strength retention of the Mg-Ca-Zn alloy bone screw were evaluated, and as a result, in the histopathological analysis using the rabbit transplantation model, the Mg-Ca-Zn alloy contained inflammatory cells in the tissue around the implant. It showed no or almost no results.
  • hematology and serum biochemical tests have been demonstrated to be acceptable before and after transplantation, and have demonstrated that the release of metallic elements from implants does not have any significant effect on normal tissue levels.
  • Mg-Ca-Zn-based alloys are excellent alternatives to orthopedic biodegradable polymers.
  • the present inventors have confirmed the excellent biocompatibility of the Mg-Ca-Zn-based alloy and tried to graft it to various fields, and as an example, tried to utilize it as a microcarrier.
  • the present inventors have previously applied for microcarriers containing Mg or Zn-based metals such as Mg or Zn alone or Mg-Zn-Ca-based alloys (Korean Patent Publication No. 2017-0115449).
  • the microcarrier was commissioned by the P & C Skin Research Center to perform a human body application test. Specifically, it measured the eye wrinkles, skin elasticity, dermal density and skin thickness, as well as the stability to evaluate its efficacy. have.
  • the present invention uses biodegradable metals including Mg or Zn metals or alloys thereof whose biocompatibility has been confirmed from the research of the present inventors, and has no side effects on biological tissues when applied to the human body by psoriasis therapy. It is possible to enhance the traction power for, and can extend its lifespan compared to conventional biodegradable polymers, and improves the drug carrying capacity of the psoriasis, which is useful as a drug carrier, and can provide drugs through a simple method It is intended to provide a therapeutic rope.
  • the present invention also seeks to provide a needle device for meditation therapy including such a meditation rope.
  • the present invention comprises a linear core comprising a biodegradable polymer
  • It includes a metal wire wound in a spiral on the outer peripheral surface of the linear core,
  • the metal wire provides a rope for psoriasis therapy comprising magnesium or zinc alone or a mixture thereof, and at least one biodegradable metal selected from magnesium or zinc alloys thereof.
  • the biodegradable metal may be represented by the following Chemical Formula 1.
  • the metal wire may have a protrusion including at least one irregular or regularly arranged plurality of protrusions.
  • the metal wire may have a protrusion having a triangular protrusion continuously arranged on one surface.
  • Rope for meditation therapy may be in the form of thorns.
  • the metal wire may be Mg having a purity of 95% or more.
  • the metal wire may be Zn having a purity of 95% or more.
  • the linear core is at least one selected from polydioxanone (PDO), polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and copolymers thereof. It may be to include a biodegradable polymer of.
  • a needle device for psoriasis therapy including a rope for psoriasis therapy according to the above embodiments.
  • the rope for meditation therapy of the present invention has a form in which a metal wire containing a biodegradable metal or alloy is spirally wrapped around a linear core containing a biodegradable polymer, so that the metal has a metal in applying biodegradable metal or alloy to meditation therapy.
  • the life of the rope can be extended, and the drug delivery system as the drug is efficiently carried in the space formed between the winding of the metal wire as well as the linear core.
  • Useful as a simple method called meditation therapy It can provide a method of administration that can deliver drugs. Furthermore, it is possible to obtain an additional effect capable of expressing a swelling effect, aka filler effect, by a mechanism in the body of a biodegradable metal or alloy.
  • the biodegradable polymer has a problem that the strength decreases due to the reduction of the cross-sectional area and the concentration of stress due to the physical processing, but in the present invention, the mechanical properties are not deteriorated because the linear core containing the biodegradable polymer itself is not physically processed.
  • Figure 1 shows an embodiment of the rope for psoriasis therapy of the present invention, an example of a structure in which a metal wire having a smooth surface is wound spirally on the outer circumferential surface of a linear core.
  • Figure 2 shows an embodiment of the rope for the meditation therapy of the present invention, an example of a structure in which a metal wire having a projection on one surface of the linear core is wrapped in a spiral
  • Figure 3 is a rope of the rope according to Figure 2 It is a longitudinal section.
  • Figure 4 shows an example of a needle device interpolated rope for psoriasis therapy of the present invention.
  • Figure 5 is a graph of the results of measuring the decomposition rate according to the sample for each component of the biodegradable metal in the biodegradable metal contained in the metal wire constituting the rope for psoriasis therapy of the present invention.
  • Figure 6 is a photograph showing the process of inserting and transplanting the rope for psoriasis therapy of the present invention in the transdermal rat.
  • FIG. 7 to 8 is an image observed by Micro-CT after inserting the rope for psoriasis therapy of the present invention into the transdermal rat, FIG. 7 is immediately after insertion, and FIG. 8 is an image 1 week after insertion.
  • the present inventors have studied the biocompatibility and efficacy effect of each application in relation to an alloy containing magnesium or zinc metal alone or as described above, and have presented the results in the form of a thesis or patent application.
  • the present invention was obtained as a result of continuously conducting research based on such a study, and the present invention was devised as a result of various efforts to apply the biodegradable metal as a drug delivery agent by psoriasis therapy.
  • the grafting of the biodegradable metal according to the present invention to the meditation therapy includes a linear core comprising a biodegradable polymer; And a metal wire spirally wound on the outer circumferential surface of the linear core, wherein the metal wire is at least one biodegradable metal selected from magnesium or zinc alone or a mixture thereof, and alloys containing magnesium or zinc as a main component thereof. It is provided as a rope for psoriasis therapy that includes.
  • the metal wire is effective in all biodegradable metals, particularly biodegradable metals including magnesium or zinc, but is not limited thereto, and for example, biodegradable metals represented by the following Chemical Formula 1 It may include.
  • X may be a metal known to not inhibit the biodegradability of the alloy, and even if the biodegradability is lean or not, it may be a metal that does not cause toxicity when it is easily discharged to the body or remains in the human body.
  • the biodegradable metal according to the present invention is a metal having the property of absorbing and decomposing in tissue and releasing metal ions and decomposition products into the body when applied as a meditation therapy, magnesium (Mg), calcium (Ca), zinc (Zn) Etc. is an alkaline metal-based biodegradable metal, and has a mechanism for releasing hydrogen gas by reacting with water, as shown in Reaction Schemes 1 to 3 below.
  • the biodegradable metal may be preferably made of magnesium (Mg) or zinc (Zn) as a single material, and is excellent in biocompatibility and does not exhibit toxicity in normal cells or tissues.
  • magnesium will be understood as magnesium having a purity of 95% or more
  • zinc will also be understood as zinc having a purity of 95% or more.
  • the biodegradable metal material may have a slightly higher decomposition rate for use alone as a long-term support. This problem can be solved by using a biodegradable polymer as a core wire to extend mutual life.
  • the biodegradable metal represented by Chemical Formula 1 can control its decomposition rate by including an intermetallic compound having a different potential.
  • an intermetallic compound having a different potential For example, two or more metal phases generate a galvanic circuit to accelerate the decomposition rate. You can.
  • the biodegradable metal may include a biodegradable metal including a Mg 2 Ca phase, a MgZn phase, or a Ca 2 Mg 6 Zn 3 phase.
  • a biodegradable metal surface represented by Chemical Formula 1 may be coated with PEO (Plasma electrolytic oxidation) coating, polymer coating, or another type of second metal.
  • the second metal may include sodium, magnesium, potassium, iron, nickel, zinc, gallium, selenium, strontium, zirconium, molybdenum, niobium, tantalum, titanium, silicon, silver, gold, manganese, calcium, and the like. It is not limited.
  • chromium (Cr) and nickel (Ni) having a stainless function should be controlled to less than 1% by mass to maintain corrosion rate and biocompatibility.
  • the biodegradable metal of the present invention itself has antibacterial activity against acne-causing bacteria.
  • the present inventors prepared a biodegradable metal composed of magnesium or zinc as a sole material and a biodegradable metal obtained by mixing different metals such as calcium with the metal in a thin plate form, and evaluated their antibacterial activity against acne-causing bacteria. As a result, it was confirmed that the biodegradable metal produced by using magnesium, calcium, or zinc as a sole material or an alloy in which a different kind of metal is mixed in a specific range has antibacterial activity itself, and thus alleviates acne including it. And a cosmetic composition for prevention has been previously filed (Korean Patent Application No. 10-2018-0078402).
  • the linear core of the rope for meditation therapy of the present invention includes a biodegradable polymer, and such a biodegradable polymer can use various biodegradable polymers known to be applied or applied to conventional meditation therapy or suture.
  • biodegradable polymers known to be applied or applied to conventional meditation therapy or suture.
  • Specific examples include polydioxanone (PDO), polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and copolymers thereof, and the like.
  • the rope for meditation therapy 100 is a metal wire containing the biodegradable metal or alloy on the outer circumferential surface of the linear core 10 containing the biodegradable polymer 20 is arranged in a spirally wrapped form.
  • one of the reasons why the metal wire 20 is arranged to be spirally wrapped around the linear core 10 may have a purpose of reducing the stiffness of the biodegradable metal or alloy. If only the biodegradable metal or alloy itself is applied in the form of wire as a rope for meditation therapy, biosafety can be secured, but the foreign body feeling may be increased. However, as in the present invention, when the metal wire is spirally wrapped around the biodegradable polymer linear core, the metal may have more flexible mechanical properties, thereby minimizing foreign body sensation.
  • the side of the drug carrier in addition to the function as a conventional chamber of the linear core including the biodegradable polymer, that is, the function as the drug carrier, the biodegradable metal is naturally formed while spirally surrounding the linear core. It can be expected that the drug carrying efficiency can be improved spatially through the space.
  • a drug such as hyaluronic acid must be applied in the form of a liquid in order to be supported on a linear core containing a polymer.
  • the water solubility is extremely low, so the amount of the drug carried on the linear core must be extremely limited. none.
  • the drug can be carried through a microscopic space, it is possible to increase the actual carrying amount even if an aqueous hyaluronic acid solution is used, and a drug having low water solubility such as hyaluronic acid With respect to, it can be supported by powder or granule itself, not aqueous solution. Of course, it is of course possible to obtain an effect of substantially increasing the amount of drug carried as necessary.
  • a spirally wrapped metal wire may be preferable because it can provide irregularities on the surface of the rope.
  • the metal wire is preferably in terms of a side capable of stably securing a microscopic space for improving the drug carrying efficiency and a more firmly improving traction force on the tissue. It may have a protrusion including at least one irregular or regularly arranged multiple protrusions.
  • the term "irregular or regularly arranged plural protrusions” means that when the sizes of the protrusions are the same or different, or when the protrusions are arranged to be continuous or not continuous, the shapes of the protrusions are the same or different. It will be understood as terms including both cases and combinations thereof.
  • FIGS. 2 to 3 An example of a rope for psoriasis therapy according to a preferred embodiment is shown in FIGS. 2 to 3, referring to this, the metal wire 20a has a protrusion 2 having a triangular protrusion continuously arranged on one surface. It may have.
  • the rope 100a for psoriasis therapy has a longitudinal cross-section (shown in FIG. 3), and accordingly
  • the size or shape of the naturally occurring microscopic space (S) has a shape that can stably carry the drug, and also, as a visible shape, it can strengthen the traction force on the tissue.
  • the rope for psoriasis therapy according to the present invention shown in FIGS. 1 to 3 is a reference to the technical idea of the present invention, and the present invention is not limited to this.
  • the rope for psoriasis therapy according to the present invention can reduce the contact area between the biodegradable polymer linear core and the tissue by having a metal wire including a biodegradable metal or alloy in a spiral wrap around the biodegradable polymer linear core. Moreover, considering the reaction mechanisms of the reaction formulas 1 to 3 in the biodegradable metals or alloys, ultimately the rope is reduced by reducing the contact area between the biodegradable polymer linear core and the tissues due to generation of hydrogen gas or other oxides. Can increase the remaining life in the tissue.
  • the rope of the present invention can not only function as a drug delivery system useful in various diseases requiring long-term drug administration, but also may be advantageous in terms of the effectiveness of stool therapy, which functions as a support in tissues.
  • the meditation therapy it is possible to thicken and strengthen the weakened muscles by inducing the incorporation of indigenous substances in the body around the rope of the present invention, and also, the rope is recognized as a foreign body in our body, and the continuous biochemical stimulation of the place where the procedure has been performed and It promotes tissue recovery and long-lasting physical and chemical stimulation enables changes in body structure and function, which can be effective in treating chronic chronic diseases.
  • These psoriasis treatments are applied to the lumbar disc, neck disc, facial paralysis sequelae, facial beauty procedures, knee arthritis, fissure shoulders, facial asymmetry or partial obesity, and serve as a support for muscles and ligaments and improve blood circulation, thereby improving pain circulation and cosmetic surgery. Effect can be expressed.
  • the rope of the present invention can function as an effective drug delivery agent for the treatment of chronic diseases by maximizing the drug-carrying efficiency and extending the life of the rope when used for such various palliative therapies, so that its efficacy can be maintained for a long time with one administration. By doing so, it is possible to reduce side effects caused by frequent and long-term drug administration of chronic patients, and it may also be desirable in terms of enabling topical drug administration in a simple manner.
  • the thickness of the linear core, etc. is not limited as long as it is generally accepted as the size of the biodegradable polymer filament for meditation therapy, and includes the biodegradable metal introduced according to the present invention.
  • a metal wire it may be desirable to have a filament thickness equivalent to that of a biodegradable polymer filament in consideration of a feeling of foreign matter in a tissue and ease of winding in a spiral.
  • the linear core and the metal wire may be 18 gauge to 30 gauge, but are not limited thereto.
  • Psoriasis therapy is a therapy that continuously treats a disease by putting the above-mentioned rope on various designed needles and injecting them into a desired area, and leaving only the rope in the stool, which can be combined with various types of needles.
  • FIG 4 shows an example of the needle mechanism 200 interpolating the rope 100a of the present invention, but is not limited thereto.
  • the biodegradable metal wire of the present invention can be invaded without irritation to the skin without exhibiting toxicity in normal cells or tissues.
  • examples of decomposition characteristics according to the metal element composition of the biodegradable metal contained in the metal wire constituting the rope of the present invention are shown, which are biodegradable metals in a linear core known as a group biodegradable polymer. It is an example to show that in case of winding, it is possible to control various decomposition rates in vivo.
  • a metal sheet (casting in a high-frequency melting furnace and then extruding at a rate of 0.1 mm / s was performed at a speed of 0.1 mm / s) with the composition (% by weight) of Table 1 below to prepare a metal sheet.
  • Mg 2 Ca phase does not produce a sample of 2 to 5 (Example 2 to 5) Samples that the metal sheet is showed and, Mg 2 Ca phase generate a hydrogen gas generation amount of the stable decomposition. 6 and 7 The amount of hydrogen gas generated in the metal sheet was significantly higher than the other examples, and thus it was confirmed that the decomposition rate was increased. Through this, it was confirmed that the decomposition rate can be adjusted through the composition control of the biodegradable metal.
  • the needle apparatus for psoriasis therapy as shown in FIG. 4 was manufactured with the standards shown in Table 3 below.
  • the length of the portion wrapped with the metal wire is adjusted among the entire length of the linear core in consideration of the length of the needle. That is, it can be confirmed that the length of the portion wrapped with the metal wire does not exceed the length of the needle so that the portion wrapped with the metal wire is completely included in the needle. This is because it is desirable to include a metal wire to the inside of the needle and interpolate with only the linear core portion exposed as a side for preventing scratch.
  • the shape of the metal wire has been described, and the metal wire is applied in the form of spirally winding a linear core.
  • the width, thickness and length of the metal wire are the size of the suture and the gauge of the needle and Of course, it can be adjusted in various ways considering the length.
  • the rope for psoriasis therapy of the present invention generates hydrogen gas in tissues, and it is possible to extend the life of the rope by reducing the contact area between the linear core made of polymer and tissue due to the generation of the hydrogen gas.
  • rats were inserted into the transdermal layer of the rope for psoriasis therapy and experiments were observed to observe them through Micro-CT.
  • polydioxanone is used as a linear core
  • the wire for meditation therapy is wrapped in a metal wire made of magnesium having a purity of 95% (0.07 mm thick and 0.7 mm wide) in the form shown in FIG. 1 (full length)
  • a needle device for psoriasis therapy as shown in FIG. 4 by preparing a length of 50 mm of the metal wire wrapped in 70 mm).
  • FIG. 7 is a Micro-CT image immediately after inserting the rope for psoriasis therapy
  • FIG. 8 is a Micro-CT image 1 week after insertion.
  • the arrows indicated in FIGS. 7 to 8 are portions in which the linear core is wrapped with a metal wire, and only the micro-CT can not confirm the linear core.
  • black spots exist around the rope, which corresponds to an air pocket caused by hydrogen gas generation as a magnesium decomposition product.
  • the rope for psoriasis therapy according to the present invention and the needle device for psoriasis therapy comprising the rope for psoriasis therapy has no side effects on biological tissues when applied to the human body as psoriasis therapy, and can enhance traction on tissues, and conventional biodegradability It can extend its lifespan compared to polymer embedding, and it is useful as a drug delivery agent by improving the drug carrying capacity of the embedding itself, and it can be useful as a device capable of delivering the drug through a simple method.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un câble de thérapie d'incorporation de fil et un appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci, et l'invention concerne un câble de thérapie d'incorporation de fil et un appareil à aiguille comprenant celui-ci, le câble comprenant une âme linéaire, qui comprend un polymère biodégradable, et un fil métallique, qui est agencé de façon à entourer en spirale la surface circonférentielle externe de l'âme linéaire, le fil métallique comprenant un métal biodégradable formé avec du magnésium ou du zinc en tant que composant principal, de façon à ne présenter aucun effet secondaire sur un tissu biologique lorsqu'il est appliqué sur le corps humain au moyen d'une thérapie d'incorporation de fil, une force de traction sur le tissu pouvant être renforcée, la durée de vie pouvant être prolongée par rapport à celle d'un fil incorporé classique d'un polymère biodégradable, la capacité de chargement de médicament du fil incorporé lui-même pouvant être augmentée de façon à permettre d'obtenir une utilité en tant que support de médicament, et un médicament pouvant être administré au moyen d'un procédé simple.
PCT/KR2019/012002 2018-09-17 2019-09-17 Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci WO2020060159A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP19862122.9A EP3854316B1 (fr) 2018-09-17 2019-09-17 Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci
CN201980057740.XA CN112672698A (zh) 2018-09-17 2019-09-17 用于埋线疗法的线及包括其的用于埋线疗法的针具
US17/276,783 US20210353822A1 (en) 2018-09-17 2019-09-17 Thread embedding therapy rope and thread embedding therapy needle apparatus comprising same
JP2021513324A JP7320301B2 (ja) 2018-09-17 2019-09-17 埋線療法用ロープ及びこれを含む埋線療法用ニードル装置

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20180110982 2018-09-17
KR10-2018-0110982 2018-09-17
KR1020190114080A KR102310568B1 (ko) 2018-09-17 2019-09-17 매선요법용 로프 및 이를 포함하는 매선요법용 니들 기구
KR10-2019-0114080 2019-09-17

Publications (1)

Publication Number Publication Date
WO2020060159A1 true WO2020060159A1 (fr) 2020-03-26

Family

ID=69887607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/012002 WO2020060159A1 (fr) 2018-09-17 2019-09-17 Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci

Country Status (2)

Country Link
JP (2) JP7320301B2 (fr)
WO (1) WO2020060159A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115804872A (zh) * 2022-11-29 2023-03-17 上海交通大学 可降解镁基金属丝材在制备溶脂材料中的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149447A1 (en) * 2002-02-01 2003-08-07 Morency Steven David Barbed surgical suture
JP2005013733A (ja) * 2003-06-24 2005-01-20 Ethicon Inc 生体崩壊性のステント
JP2008062061A (ja) * 2006-09-06 2008-03-21 Tyco Healthcare Group Lp とげのある縫合糸における生体活性物質
KR20160000824A (ko) * 2014-06-25 2016-01-05 김동진 금속 코팅 가시매선
KR20170115429A (ko) * 2016-04-07 2017-10-17 랩앤피플주식회사 생체분해성 금속을 이용한 마이크로 니들
KR20180078402A (ko) 2016-12-29 2018-07-10 한국산업기술대학교산학협력단 개 코로나 바이러스의 신속 진단을 위한 pcr 기기 및 시스템

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4255960B2 (ja) 2006-06-16 2009-04-22 克弥 高須 形成外科用手術糸
CA2802753C (fr) 2010-06-21 2018-07-31 Zorion Medical, Inc. Implants bioabsorbables
WO2017176077A1 (fr) 2016-04-07 2017-10-12 랩앤피플주식회사 Micro-aiguille mettant en œuvre un métal biodégradable

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149447A1 (en) * 2002-02-01 2003-08-07 Morency Steven David Barbed surgical suture
JP2005013733A (ja) * 2003-06-24 2005-01-20 Ethicon Inc 生体崩壊性のステント
JP2008062061A (ja) * 2006-09-06 2008-03-21 Tyco Healthcare Group Lp とげのある縫合糸における生体活性物質
KR20160000824A (ko) * 2014-06-25 2016-01-05 김동진 금속 코팅 가시매선
KR101641299B1 (ko) 2014-06-25 2016-07-20 김동진 금속 코팅 가시매선
KR20170115429A (ko) * 2016-04-07 2017-10-17 랩앤피플주식회사 생체분해성 금속을 이용한 마이크로 니들
KR20170115449A (ko) 2016-04-07 2017-10-17 랩앤피플주식회사 생체분해성 금속을 이용한 마이크로 니들
KR20180078402A (ko) 2016-12-29 2018-07-10 한국산업기술대학교산학협력단 개 코로나 바이러스의 신속 진단을 위한 pcr 기기 및 시스템

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115804872A (zh) * 2022-11-29 2023-03-17 上海交通大学 可降解镁基金属丝材在制备溶脂材料中的应用
CN115804872B (zh) * 2022-11-29 2024-02-27 上海交通大学 可降解镁基金属丝材在制备溶脂材料中的应用

Also Published As

Publication number Publication date
JP7320301B2 (ja) 2023-08-03
JP2023106523A (ja) 2023-08-01
JP2022500123A (ja) 2022-01-04

Similar Documents

Publication Publication Date Title
RU2640700C2 (ru) Магниевый сплав, способ его производства и использования
US8999367B1 (en) Bioabsorbable substrates and systems that controllably release antimicrobial metal ions
RU2647951C2 (ru) Магниевый сплав, способ его производства и использования
Brar et al. Magnesium as a biodegradable and bioabsorbable material for medical implants
KR102310568B1 (ko) 매선요법용 로프 및 이를 포함하는 매선요법용 니들 기구
US9821094B2 (en) Coatings for the controllable release of antimicrobial metal ions
US9114197B1 (en) Coatings for the controllable release of antimicrobial metal ions
WO2008025840A2 (fr) Revêtements structurés pour implants et leur procédé de fabrication
EP2411060A2 (fr) Dispositifs médicaux comportant des particules galvaniques
CN109652691B (zh) 一种金属埋线及其制备方法与应用
WO2011130112A1 (fr) Dispositifs médicaux à matières particulaires galvaniques
EP2734248B1 (fr) Grille d'élution de médicament destiné à prévenir une infection des dispositifs transcutanés résidents
WO2020060159A1 (fr) Câble de thérapie d'incorporation de fil et appareil à aiguille de thérapie d'incorporation de fil comprenant celui-ci
CN108165782A (zh) 一种医用锌基合金带材及其制备方法
EP3950989A1 (fr) Implant pour zone non luminale
CN104645422B (zh) 一种具有强烈抗菌功能的生物可降解镁合金
Santos et al. Bioresorbable metallic implants: Surface functionalization with nanoparticles and nanostructures
JP2011515388A (ja) 頭痛を治療するための固形製剤
EP2512589B1 (fr) Dispositif permettant d'administrer des médicaments et d'influencer les effets de médicaments
EP0430035B1 (fr) Utilisation des benzothiazépines pour l'obtention d'un médicament pour le traitement des crises épileptiques
CN220632144U (zh) 一种缝合线装置
EP3562522A1 (fr) Dispositif comportant un matériau résorbable à action antibactérienne
RU2199978C2 (ru) Имплантат для хирургического лечения туберкулезного спондилита
CN115804872B (zh) 可降解镁基金属丝材在制备溶脂材料中的应用
DE20321445U1 (de) Otorhinologische Abgabevorrichtung

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19862122

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021513324

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019862122

Country of ref document: EP

Effective date: 20210419